Lactose Intolerance Market
授權報價
| Single User License | $4,500 USD |
| Multiple User License | $5,500 USD |
| Custom Research License | $8,000 USD |
完整報告名稱與涵蓋範圍
Lactose Intolerance Market - Global Industry Size, Share, Trends, Opportunity & Forecast, Segmented By Type (Primary, Secondary, Congenital, Developmental), By Diagnosis (Hydrogen breath test, Glucose blood test, Stool acidity test), By Region & Competition, 2021-2031F
報告摘要
Market Overview
The global lactose intolerance market is projected to expand significantly, from USD 21.67 billion in 2025 to USD 32.14 billion by 2031, growing at a 6.79% CAGR. This market includes specifically formulated lactose-free dairy products, such as milk, yogurt, and cheese, alongside lactase enzyme supplements designed to aid individuals with lactose malabsorption. Key drivers supporting this growth are the increasing diagnosis of digestive sensitivities and a rising consumer preference for products offering dairy's nutritional benefits without gastrointestinal discomfort. Furthermore, technological advancements in enzymatic processes have greatly enhanced the flavor profile of lactose-free offerings, eliminating the previous overly sweet taste and thereby boosting consumer acceptance, as evidenced by a 13.6% dollar growth in US lactose-free milk sales in 2024.
Despite this growth, a significant challenge hindering broader market expansion is the intense competition from the burgeoning plant-based dairy alternative sector. Consumers are increasingly gravitating towards naturally lactose-free options like oat, almond, and soy beverages, which are often perceived as more environmentally sustainable and ethically preferable to animal-derived dairy. This shift forces lactose-free dairy manufacturers to contend not only with taste and price competition but also with changing lifestyle values that divert a portion of the target demographic toward non-dairy substitutes.
Market Driver
Strategic product diversification and portfolio expansion by key players have become a primary engine for market growth, with major dairy conglomerates investing in premium lactose-free formulations to cater to evolving tastes. Companies are moving beyond basic fluid milk to offer ultra-filtered, high-protein, and flavored options that retain nutritional value while eliminating digestive discomfort. This strategy effectively captures mainstream consumers who might otherwise drift to plant-based alternatives, as evidenced by the Fairlife brand's 28% year-over-year dollar sales surge to $782 million in the refrigerated white milk category, underscoring the commercial viability of specialized portfolios and mirroring the overall 8.5% dollar value increase in lactose-free dairy product sales for the 52 weeks ending July 13, 2025.
Concurrently, the growing consumer focus on digestive wellness and gut health is reshaping demand, prompting shoppers to prioritize products offering gastrointestinal comfort. This trend is particularly evident in fermented dairy, where perceived probiotic benefits are amplified by lactose-free claims, appealing to health-conscious demographics seeking functional nutrition. This shift represents a move toward actively managing gut biomes rather than merely avoiding intolerance symptoms, with lactose-free yogurt sales rising by 43% compared to the prior year, validating the strong correlation between digestive health positioning and consumer purchasing behavior and indicating that digestive wellness is a central global consumption driver.
Market Challenge
Competition from the plant-based dairy alternative sector poses a direct impediment to the growth of the Global Lactose Intolerance Market. While specifically formulated lactose-free dairy products address the medical necessity of avoiding lactose, plant-based beverages such as oat and almond intrinsically offer a lactose-free profile that naturally appeals to the same consumer base. This overlap creates a divided market where individuals seeking relief from digestive discomfort are increasingly swayed by the additional environmental and ethical value propositions of plant-based options. Consequently, this shift diverts a portion of the core demographic away from reformulated animal-based dairy, eroding the potential market share for manufacturers who rely on these consumers for revenue expansion.
The magnitude of this competitive pressure is evidenced by the financial performance of the non-dairy sector, which saw global sales of non-dairy alternatives reach $22.4 billion in 2024, representing a 5 percent increase from the prior year. This sustained growth demonstrates that consumers are actively choosing non-dairy solutions over modified dairy products. As a result, lactose-free dairy producers face a shrinking captive audience, forcing them to contend with a competitor that satisfies the primary need for digestive comfort while simultaneously addressing lifestyle values that animal-derived products cannot match.
Market Trends
The expansion of private label and retailer-owned brands is fundamentally altering the competitive landscape, as major grocers aggressively develop proprietary lactose-free lines to offer cost-effective alternatives to national brands. This trend is driven by price-sensitive consumers who require the digestive benefits of lactose-free staples, such as milk and cheese, but are increasingly deterred by the premium pricing of branded functional dairy. Retailers are responding by optimizing their supply chains to deliver high-quality, store-brand formulations that mimic the taste and nutritional profile of established competitors, thereby democratizing access to these essential products. The commercial impact of this shift is evident in recent performance metrics, with private label dollar sales across all outlets increasing by 4.4% for the six months ending June 15, 2025, significantly outpacing the 1.1% gain recorded by national brands, particularly in refrigerated products.
Simultaneously, the emergence of precision fermentation for animal-free dairy represents a technological leap designed to decouple dairy protein production from conventional animal agriculture while maintaining authentic taste and texture. Unlike plant-based substitutes that often struggle to replicate the melt and mouthfeel of casein and whey, precision fermentation utilizes microbial hosts to produce bio-identical dairy proteins, appealing to ethical consumers who demand the functional experience of real dairy without the environmental footprint or animal welfare concerns. This sector is rapidly moving from R&D to commercialization, attracting substantial capital to scale manufacturing capabilities, exemplified by the food ingredient company Vivici raising a $34 million Series A funding round to expand operations and accelerate the market entry of fermentation-derived beta-lactoglobulin, signaling strong investor confidence in this animal-free category's long-term viability.
Key Market Players
* Nestle S.A.
* Danone S.A.
* Fonterra Co-operative Group Limited
* Valio Oy
* Lactalis Group
* Arla Foods amba
* The a2 Milk Company Limited
* Saputo Inc.
* Abbott Laboratories
* Johnson & Johnson Services, Inc.
Report Scope
In this report, the Global Lactose Intolerance Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
# Lactose Intolerance Market, By Type
* Primary
* Secondary
* Congenital
* Developmental
# Lactose Intolerance Market, By Diagnosis
* Hydrogen breath test
* Glucose blood test
* Stool acidity test
# Lactose Intolerance Market, By Region
* North America
United States
Canada
Mexico
* Europe
France
United Kingdom
Italy
Germany
Spain
* Asia Pacific
China
India
Japan
Australia
South Korea
* South America
Brazil
Argentina
Colombia
* Middle East & Africa
South Africa
Saudi Arabia
UAE
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the Global Lactose Intolerance Market.
Available Customizations:
Global Lactose Intolerance Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
* Detailed analysis and profiling of additional market players (up to five).
目錄 Table of Contents
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
5. Global Lactose Intolerance Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Type (Primary, Secondary, Congenital, Developmental)
5.2.2. By Diagnosis (Hydrogen breath test, Glucose blood test, Stool acidity test)
5.2.3. By Region
5.2.4. By Company (2025)
5.3. Market Map
6. North America Lactose Intolerance Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Type
6.2.2. By Diagnosis
6.2.3. By Country
6.3. North America: Country Analysis
6.3.1. United States Lactose Intolerance Market Outlook
6.3.1.1. Market Size & Forecast
6.3.1.1.1. By Value
6.3.1.2. Market Share & Forecast
6.3.1.2.1. By Type
6.3.1.2.2. By Diagnosis
6.3.2. Canada Lactose Intolerance Market Outlook
6.3.2.1. Market Size & Forecast
6.3.2.1.1. By Value
6.3.2.2. Market Share & Forecast
6.3.2.2.1. By Type
6.3.2.2.2. By Diagnosis
6.3.3. Mexico Lactose Intolerance Market Outlook
6.3.3.1. Market Size & Forecast
6.3.3.1.1. By Value
6.3.3.2. Market Share & Forecast
6.3.3.2.1. By Type
6.3.3.2.2. By Diagnosis
7. Europe Lactose Intolerance Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Type
7.2.2. By Diagnosis
7.2.3. By Country
7.3. Europe: Country Analysis
7.3.1. Germany Lactose Intolerance Market Outlook
7.3.1.1. Market Size & Forecast
7.3.1.1.1. By Value
7.3.1.2. Market Share & Forecast
7.3.1.2.1. By Type
7.3.1.2.2. By Diagnosis
7.3.2. France Lactose Intolerance Market Outlook
7.3.2.1. Market Size & Forecast
7.3.2.1.1. By Value
7.3.2.2. Market Share & Forecast
7.3.2.2.1. By Type
7.3.2.2.2. By Diagnosis
7.3.3. United Kingdom Lactose Intolerance Market Outlook
7.3.3.1. Market Size & Forecast
7.3.3.1.1. By Value
7.3.3.2. Market Share & Forecast
7.3.3.2.1. By Type
7.3.3.2.2. By Diagnosis
7.3.4. Italy Lactose Intolerance Market Outlook
7.3.4.1. Market Size & Forecast
7.3.4.1.1. By Value
7.3.4.2. Market Share & Forecast
7.3.4.2.1. By Type
7.3.4.2.2. By Diagnosis
7.3.5. Spain Lactose Intolerance Market Outlook
7.3.5.1. Market Size & Forecast
7.3.5.1.1. By Value
7.3.5.2. Market Share & Forecast
7.3.5.2.1. By Type
7.3.5.2.2. By Diagnosis
8. Asia Pacific Lactose Intolerance Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Type
8.2.2. By Diagnosis
8.2.3. By Country
8.3. Asia Pacific: Country Analysis
8.3.1. China Lactose Intolerance Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Type
8.3.1.2.2. By Diagnosis
8.3.2. India Lactose Intolerance Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Type
8.3.2.2.2. By Diagnosis
8.3.3. Japan Lactose Intolerance Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Type
8.3.3.2.2. By Diagnosis
8.3.4. South Korea Lactose Intolerance Market Outlook
8.3.4.1. Market Size & Forecast
8.3.4.1.1. By Value
8.3.4.2. Market Share & Forecast
8.3.4.2.1. By Type
8.3.4.2.2. By Diagnosis
8.3.5. Australia Lactose Intolerance Market Outlook
8.3.5.1. Market Size & Forecast
8.3.5.1.1. By Value
8.3.5.2. Market Share & Forecast
8.3.5.2.1. By Type
8.3.5.2.2. By Diagnosis
9. Middle East & Africa Lactose Intolerance Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Type
9.2.2. By Diagnosis
9.2.3. By Country
9.3. Middle East & Africa: Country Analysis
9.3.1. Saudi Arabia Lactose Intolerance Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Type
9.3.1.2.2. By Diagnosis
9.3.2. UAE Lactose Intolerance Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Type
9.3.2.2.2. By Diagnosis
9.3.3. South Africa Lactose Intolerance Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Type
9.3.3.2.2. By Diagnosis
10. South America Lactose Intolerance Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Type
10.2.2. By Diagnosis
10.2.3. By Country
10.3. South America: Country Analysis
10.3.1. Brazil Lactose Intolerance Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Type
10.3.1.2.2. By Diagnosis
10.3.2. Colombia Lactose Intolerance Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Type
10.3.2.2.2. By Diagnosis
10.3.3. Argentina Lactose Intolerance Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Type
10.3.3.2.2. By Diagnosis
11. Market Dynamics
11.1. Drivers
11.2. Challenges
12. Market Trends & Developments
12.1. Merger & Acquisition (If Any)
12.2. Product Launches (If Any)
12.3. Recent Developments
13. Global Lactose Intolerance Market: SWOT Analysis
14. Porter's Five Forces Analysis
14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Products
15. Competitive Landscape
15.1. Nestle S.A.
15.1.1. Business Overview
15.1.2. Products & Services
15.1.3. Recent Developments
15.1.4. Key Personnel
15.1.5. SWOT Analysis
15.2. Danone S.A.
15.3. Fonterra Co-operative Group Limited
15.4. Valio Oy
15.5. Lactalis Group
15.6. Arla Foods amba
15.7. The a2 Milk Company Limited
15.8. Saputo Inc.
15.9. Abbott Laboratories
15.10. Johnson & Johnson Services, Inc.
16. Strategic Recommendations
17. About Us & Disclaimer
提及公司
同分類最新報告(醫療與生命科學)
常見問題
這份報告可以先索取樣本嗎?
可以。建議購買前先申請樣本,提出申請後約 2 個工作天內提供,您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算?
報告以美元標價,台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本(單人/多人/企業全站)價格不同,量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付?如何付款?
一般 3–7 個工作天交付,實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票,30 天內電匯付款即可。
量子訊息有限公司為 TechSci Research 在台灣的授權代理,提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們